Sector revisions Caplin Point Laboratories Limited

Stocks

Market Closed - Bombay S.E. 18:02:30 01/10/2026 HKT			5-day change	1st Jan Change
2,632.35 ^INR	-2.82%		-5.69%	+42.97%

09-25	Caplin Point Laboratories Limited Approves Appointment of D Muralidharan as Whole Time Director	CI
08-15	Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	CAPLIN POINT LABORATORIES LIMITED							2
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	MERCK & CO., INC.							25
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							23
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							26
	NOVO NORDISK A/S							23
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	BRISTOL-MYERS SQUIBB COMPANY							24
	MCKESSON CORPORATION							14
	GSK PLC							21
	SANOFI							24
	MODERNA, INC.							18
	REGENERON PHARMACEUTICALS, INC.							26
	MERCK KGAA							14
	Average							22
	Weighted average by Cap.							25